Enhancing the Pharmacological Properties of Triterpenes Through Acetylation: An Anticancer and Antioxidant Perspective
Molecules · 19.06.2025 · 30 (12) · 2661
DOI: 10.3390/molecules30122661 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 19.06.2025. Verfasst von Barbara Bednarczyk-Cwynar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Organic Chemistry, Faculty of Pharmacy, Poznan University of Medical Sciences, Collegium Pharmaceuticum 2, (CP.2), Rokietnicka Str. 3, …. Hauptthemen laut MEDLINE: Triterpenes, Antioxidants, Antineoplastic Agents. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Poznan University of Medical Sciences.
Abstract (Originalsprache)
This paper presents the influence of acetylation on the cytotoxic and antioxidant activity of natural triterpenes. Oleanolic acid, betulin, betulinic acid and other triterpenes have been modified to improve their pharmacological properties. Acylation of the hydroxyl group at the C-3 position showed significant changes in biological activity, in particular against cancer cell lines such as HeLa, A-549, MCF-7, PC-3 and SKOV-3, with the highest IC50 results for acetyloleanolic acid (1b) and acetylbetulinic acid (4b). Docking results showed that all compounds tested demonstrated the ability to bind to pockets (C1–C5) of the p53 Y220 protein, obtaining different Vina score values. The strongest binding was observed for compound 2b in the C3 pocket (−10.1 kcal × mol−1), while in the largest C1 pocket, the best result was achieved by compound 5b (−9.1 kcal × mol−1). Moreover, antioxidant studies using the CUPRAC and DPPH tests showed significant differences in the mechanisms of action of the compounds depending on the structure. The analyses of ADMETox confirmed the favorable pharmacokinetic profile and low toxicity of most of the tested derivatives. The results suggest that acetylated triterpenes, especially 1b and 4b, have great potential as anticancer drug candidates, requiring further research on their cytotoxic activity and structural modifications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Organic Chemistry, Faculty of Pharmacy, Poznan University of Medical Sciences, Collegium Pharmaceuticum 2, (CP.2), Rokietnicka Str. 3, 60-806 Poznan, Poland.
- Center of Innovative Pharmaceutical Technology (CITF), Rokietnicka Str. 3, 60-806 Poznan, Poland.
- Department of Pharmacology, Faculty of Pharmacy, Poznan University of Medical Sciences, Collegium Pharmaceuticum 1 (CP.1), Rokietnicka Str. 3, 60-806 Poznan, Poland.
- Department of Pharmacognosy and Biomaterials, Faculty of Pharmacy, Poznan University of Medical Sciences, Collegium Pharmaceuticum 1 (CP.1), Rokietnicka Str. 3, 60-806 Poznan, Poland.
- Department of Clinical Pathology, Faculty of Medical Sciences, Poznan University of Medical Sciences, Przybyszewskiego Str. 49, 60-355 Poznan, Poland.
ORCID-Profile: Barbara Bednarczyk-Cwynar, Piotr Ruszkowski, Andrzej Günther, Szymon Sip, Przemysław Zalewski
Förderung
- Poznan University of Medical Sciences
Zitieren
APA
Bednarczyk-Cwynar, B., Ruszkowski, P., Günther, A., Sip, S., Bednarek-Rajewska, K., & Zalewski, P. (2025). Enhancing the Pharmacological Properties of Triterpenes Through Acetylation: An Anticancer and Antioxidant Perspective. Molecules, 30(12), 2661. https://doi.org/10.3390/molecules30122661
Vancouver
Bednarczyk-Cwynar B, Ruszkowski P, Günther A, Sip S, Bednarek-Rajewska K, Zalewski P. Enhancing the Pharmacological Properties of Triterpenes Through Acetylation: An Anticancer and Antioxidant Perspective. Molecules. 2025;30(12):2661. doi:10.3390/molecules30122661
BibTeX
@article{BednarczykCwynar2025,
author = {Bednarczyk-Cwynar, Barbara and Ruszkowski, Piotr and Günther, Andrzej and Sip, Szymon and Bednarek-Rajewska, Katarzyna and Zalewski, Przemysław},
title = {Enhancing the Pharmacological Properties of Triterpenes Through Acetylation: An Anticancer and Antioxidant Perspective},
journal = {Molecules},
year = {2025},
volume = {30},
number = {12},
pages = {2661},
doi = {10.3390/molecules30122661}
}
EUVIMED